RICERCA
AUTORI
RIVISTE
Sfoglia per AUTORE
DI MAIO M
Collezione ASL Asti
Items : 26
Safety profile of darolutamide versus placebo: a systematic review and meta-analysis. in Prostate cancer and prostatic diseases / Prostate Cancer Prostatic Dis. 2024 Sep;27(3):385-392. doi: 10.1038/s41391-023-00775-y. Epub 2023 De
2024
ASL Asti
AO Ordine Mauriziano
Di Maio M; Tucci M; Vogl UM; Buttigliero C; Tombal B; Cathomas R; Smith MR; Fizazi K; Treglia G; Turco F; Gillessen S;
Hormonal Agents in Localized and Advanced Prostate Cancer: Current Use and Future Perspectives. in Clinical genitourinary cancer / Clin Genitourin Cancer. 2024 Oct;22(5):102138. doi: 10.1016/j.clgc.2024.102138. Epub 2024 Jun 12.
2024
ASL Asti
AOU San Luigi di Orbassano
AO Ordine Mauriziano
Tucci M; Scagliotti GV; Di Maio M; Palesandro E; Poletto S; Calabrese M; Saporita I; Crespi V; Farinea G; Di Stefano RF; Gallina A; Fossati N; Zilli T; Delcuratolo MD; Gillessen S; Turco F; Vogl UM; Buttigliero C;
Treatment of bone metastases from solid tumors with bone-modifying agents: a web survey of Italian oncologists investigating patterns of practice drug prescription and prevention of side effects. in Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer / Support Care Cancer. 2024 Mar 1;32(3):202. doi: 10.1007/s00520-024-08392-8.
2024
ASL Asti
AOU Alessandria
AO Ordine Mauriziano
Cinieri S; Comandone A; Airoldi M; Rossi M; Rossetti G; Lanzetta G; Cavanna L; Bossi P; Ibrahim T; De Giorgi U; Tucci M; Santini D; Fusco V; Di Maio M; Valsecchi AA;
Management of cancer treatment-induced bone loss in patients with breast and hormone sensitive prostate cancer: AIOM survey. in Tumori / Tumori. 2024 Jun;110(3):174-185. doi: 10.1177/03008916241236279. Epub 2024 Mar 10.
2024
ASL Asti
AOU Alessandria
AO Ordine Mauriziano
Cinieri S; Vignani F; Valsecchi AA; Fusco V; Dionisio R; De Giorgi U; Di Maio M; Santini D; Tucci M;
Bone health and body composition in prostate cancer: Meet-URO and AIOM consensus about prevention and management strategies. in ESMO open / ESMO Open. 2024 Jul;9(7):103484. doi: 10.1016/j.esmoop.2024.103484. Epub 2024 Jun 19.
2024
AOU Alessandria
ASL Cuneo 2
AOU Città della Salute di Torino
ASL Asti
De Giorgi U; Santini D; Bertoldo F; Tucci M; Valsecchi AA; Procopio G; Berruti A; Di Maio M; Pantano F; Cursano MC;
Maximal androgen blockade therapy (MAB) for prostate cancer (PC) and risk of bone fractures: A systematic literature review and meta-analysis in Journal of Clinical Oncology
2024
ASL Asti
Turco F; Saporita I; Calabrese M; Carfi FM; Mogavero A; Treglia G; Gillessen S; Di Maio M; Tucci M; ButtIgliero C; Vogl U;
Therapeutic sequencing in advanced renal cell carcinoma: How to choose considering clinical and biological factors. in Critical reviews in oncology/hematology / Crit Rev Oncol Hematol. 2023 Jan;181:103881. doi: 10.1016/j.critrevonc.2022.103881. Epub 2022 Nov 24
2023
AO Ordine Mauriziano
ASL Asti
AOU San Luigi di Orbassano
Scagliotti GV; Buttigliero C; Di Maio M; Audisio A; Brusa F; Ungaro A; Audisio M; Samuelly A; Turco F; Di Stefano RF; Tucci M; Delcuratolo MD;
Role of radium-223 discontinuation due to adverse events in castration-resistant prostate cancer patients. A retrospective monocentric analysis. in Tumori / Tumori. 2023 Apr;109(2):233-243. doi: 10.1177/03008916221077144. Epub 2022 Mar 31.
2023
ASL Asti
ASL Torino 4
AO Ordine Mauriziano
AOU San Luigi di Orbassano
Buttigliero C; Di Maio M; Scagliotti GV; Ungaro A; Parlagreco E; Audisio A; Audisio M; Angusti T; Parente A; Di Stefano RF; Urban S; Pisano C; Samuelly A; Tucci M; Turco F;
2088P Management of cancer treatment-induced bone loss in patients with breast and hormone sensitive prostate cancer: AIOM survey among Italian oncologists in Annals of Oncology
2023
ASL Asti
Valsecchi AA; Fusco V; Di Maio M; Santini D; Tucci M; De Giorgi UFF; Dionisio R; Vignani F; Cinieri S;
New emerging targets in advanced urothelial carcinoma: Is it the primetime for personalized medicine? in Critical reviews in oncology/hematology / Crit Rev Oncol Hematol. 2022 Jun;174:103682. doi: 10.1016/j.critrevonc.2022.103682. Epub 2022 Apr 11
2022
ASL Asti
ASL Torino 4
ASL Cuneo 1
ASL Cuneo 2
AO Ordine Mauriziano
AOU San Luigi di Orbassano
Buttigliero C; Scagliotti GV; Di Maio M; Ortega C; Di Prima L; Audisio A; Turco F; Ungaro A; Parlagreco E; Di Stefano RF; Audisio M; Tucci M;
Antibody-Drug Conjugates in Urothelial Carcinoma: A New Therapeutic Opportunity Moves from Bench to Bedside. in Cells / Cells. 2022 Feb 25;11(5):803. doi: 10.3390/cells11050803.
2022
ASL Asti
ASL Torino 4
AO Ordine Mauriziano
AOU San Luigi di Orbassano
Delcuratolo MD; Ungaro A; Buttigliero C; Di Maio M; Audisio A; Di Prima L; Turco F; Scagliotti GV; Pisano C; Tucci M;
Prognostic factors in metastatic castration resistant prostate cancer patients treated with radium-223: a retrospective study. in Minerva urology and nephrology / Minerva Urol Nephrol. 2022 Dec;74(6):703-713. doi: 10.23736/S2724-6051.22.04701-2. Epub 2022 Feb 11.
2022
ASL Asti
ASL Torino 4
AO Ordine Mauriziano
AOU San Luigi di Orbassano
Pisano C; DI Maio M; Tucci M; Scagliotti GV; Samuelly A; DI Stefano RF; Turco F; Bungaro M; Parente A; Buttigliero C; Angusti T;
Treatment intensification for metastatic prostate cancer: New treatment landscapes in androgen deprivation-based therapy. in Cancer communications (London, England) / Cancer Commun (Lond). 2022 Aug;42(8):683-688. doi: 10.1002/cac2.12340. Epub 2022 Jul 22.
2022
ASL Asti
ASL Cuneo 2
ASL Torino 4
ASL Cuneo 1
AO Ordine Mauriziano
AOU San Luigi di Orbassano
Turco F; Ungaro A; Audisio M; Scagliotti GV; Di Maio M; Delcuratolo MD; Audisio A; Ortega C; Pisano C; Buttigliero C; Di Stefano RF; Tucci M;
A systematic review and meta-analysis of trials assessing PD-1/PD-L1 immune checkpoint inhibitors activity in pre-treated advanced stage malignant mesothelioma. in Critical reviews in oncology/hematology / Crit Rev Oncol Hematol. 2022 Apr;172:103639. doi: 10.1016/j.critrevonc.2022.103639. Epub 2022 Feb 19
2022
ASL Asti
AOU Città della Salute di Torino
ASL Torino 4
AO Ordine Mauriziano
AOU San Luigi di Orbassano
Novello S; Scagliotti GV; Carnio S; Buffoni L; Passiglia F; Zichi C; Capelletto E; Reale ML; Artusio E; Olmetto E; Bertaglia V; Paratore C; Bungaro M; Curcio H; De Luca E; Tagliamento M; Audisio M; Rapetti SG; Bironzo P; Pignataro D; Di Maio M;
1444P Cancer diagnosis communication: The perspective of oncologists, patients and caregivers in Annals of Oncology
2022
ASL Asti
Paratore C; Pacchiana Parravicini MV; Cantale O; Carfì F; Zichi C; Gamba T; Pignataro D; Samuelly A; Tucci M; Di Maio M; Novello S;
Prognostic role of the duration of response to androgen deprivation therapy in patients with metastatic castration resistant prostate cancer treated with enzalutamide or abiraterone acetate. in Prostate cancer and prostatic diseases / Prostate Cancer Prostatic Dis. 2021 Sep;24(3):812-825. doi: 10.1038/s41391-021-00336-1. Epub 2021 Fe
2021
ASL Asti
ASL Vercelli
AO Ordine Mauriziano
Di Maio M; Scagliotti GV; Gallicchio M; Vignani F; Pisano C; Bungaro M; Samuelly A; Turco F; Tucci M; Di Stefano RF; Buttigliero C;
Renal cell carcinoma (RCC): fatter is better? A review on the role of obesity in RCC. in Endocrine-related cancer / Endocr Relat Cancer. 2021 Jun 2;28(7):R207-R216. doi: 10.1530/ERC-20-0457.
2021
ASL Asti
ASL Vercelli
AO Ordine Mauriziano
AOU San Luigi di Orbassano
Buttigliero C; Di Maio M; Scagliotti GV; Pisano C; Audisio M; Samuelly A; Bungaro M; Tucci M; Di Stefano RF; Turco F;
Interactions between androgen receptor signaling and other molecular pathways in prostate cancer progression: Current and future clinical implications. in Critical reviews in oncology/hematology / Crit Rev Oncol Hematol. 2021 Jan;157:103185. doi: 10.1016/j.critrevonc.2020.103185. Epub 2020 Nov 27
2021
ASL Asti
AOU San Luigi di Orbassano
ASL Vercelli
AO Ordine Mauriziano
Buttigliero C; Di Maio M; Scagliotti GV; Di Stefano RF; Turco F; Tucci M; Pisano C;
Prognostic role of platelet-to-lymphocyte ratio and neutrophil-to-lymphocyte ratio in patients with metastatic castration resistant prostate cancer treated with abiraterone or enzalutamide. in Minerva urology and nephrology / Minerva Urol Nephrol. 2021 Dec;73(6):803-814. doi: 10.23736/S2724-6051.21.04186-2. Epub 2021 Mar 29.
2021
ASL Asti
AOU San Luigi di Orbassano
ASL Vercelli
ASL Torino 4
AO Ordine Mauriziano
Buttigliero C; DI Maio M; Scagliotti GV; Tarenghi F; Vignani F; Bungaro M; Samuelly A; Turco F; DI Stefano RF; Tucci M; Pisano C;
COVID-19 infection in cancer patients: what has been the contribution of Associazione Italiana Oncologia Medica (AIOM) to oncological care since the beginning of the first pandemic wave? in ESMO open / ESMO Open. 2021 Apr;6(2):100100. doi: 10.1016/j.esmoop.2021.100100. Epub 2021 Mar 19.
2021
ASL Asti
ASL Vercelli
AO Ordine Mauriziano
Cinieri S; Tucci M; Beretta GD; La Verde N; Giuffrida D; Del Mastro L; De Giorgi U; Chiari R; Russo A; Di Maio M; Silvestris N; Perrone F;
P45.12 Renal Function Change During Alectinib in ALK Rearranged Non-Small Cell Lung Cancer: A Retrospective Multicentre Analysis in Journal of Thoracic Oncology
2021
ASL Asti
Di Maio M; Tucci M; Novello S; Pignataro D; Paratore C;
2021
ASL Torino 3
ASL Torino 5
ASL Torino 4
ASL VCO
ASL Alessandria
ASL Asti
AOU Città della Salute di Torino
ASL Città di Torino
AOU Alessandria
ASL Biella
Di Maio M; Buffoni L; Traverso E; Tucci M; Fanchini L; Pignataro D; Saggia C; Carnio S; Bustreo S; Buosi R; Vavalà T; Boglione A; Spadi R; Bironzo P;
Evaluation of Cognitive Function in Trials Testing New-Generation Hormonal Therapy in Patients with Prostate Cancer: A Systematic Review. in Cancers / Cancers (Basel). 2020 Sep 9;12(9):2568. doi: 10.3390/cancers12092568.
2020
ASL Asti
AO Ordine Mauriziano
AOU San Luigi di Orbassano
ASL Vercelli
Tucci M; Di Maio M; Necchi A; Gamba T; Buttigliero C; Vignani F; Marandino L;
Bipolar androgen therapy in prostate cancer: Current evidences and future perspectives. in Critical reviews in oncology/hematology / Crit Rev Oncol Hematol. 2020 Aug;152:102994. doi: 10.1016/j.critrevonc.2020.102994. Epub 2020 May 24
2020
ASL Asti
AOU San Luigi di Orbassano
ASL Vercelli
AO Ordine Mauriziano
Di Maio M; Tucci M; Scagliotti GV; Vignani F; Turco F; Tabbò F; Pisano C; Di Stefano RF; Buttigliero C; Leone G;
Evaluation of cognitive function (CogF) in trials testing new-generation hormonal treatments (NGHT) in patients with prostate cancer (PC): A systematic review in Annals of Oncology
2020
ASL Asti
Marandino L; Buttigliero C; Vignani F; Gamba T; Necchi A; Tucci M; Di Maio M;
Moving from the CLEOPATRA study to real life: Results from the G.O.N.O. SUPER trial in Journal of Clinical Oncology
2018
ASL Asti
AOU Città della Salute di Torino
AO Ordine Mauriziano
Garrone O; Giarratano T; Saggia C; Bertolini I; Beano A; Blondeaux E; Riva F; D'Onofrio L; Merlini L; Coltelli L; La Verde NM; Vandone AM; Milani A; Collovà E; Ardito R; Airoldi M; De Conciliis E; Blasi L; Di Maio M; Merlano MC;